In line with reports that the estrogen receptor (ER) regulates KDM4B expression [29], we observed upregulation of KDM4B in ER+ but not in ER- or TN tumors in agreement with KDM4B's oncogenic activity in other tumor types [10, 30, 31]. This evidence concerns the gene ESR1 and neoplasm.